Drug metabolism and pharmacokinetics (DMPK) has become one of the core disciplines in the drug discovery process that focuses on evaluating the safety and efficacy of the drug candidates. Sub-optimal DMPK profile has been one of the major reasons for the attrition of drug at the clinical phase of the trial indicating the poor ADME properties (Absorption, Digestion, Metabolism and Excretion) and drug-drug interaction (DDI). Our 3D hepatocyte spheroids are suitable for long-term culture with enhanced hepatocyte phenotype like albumin secretion, CYP activity for testing drug induced toxicity and metabolism
Pandorum’s 3D organoids containing multi-lineage cell types recapitulate the native microenvironment with parenchymal hepatocytes co-cultured with kupffer cells, hepatic stellate cells and liver endothelial cells. These organoids are induced to recapitulate the complex disease phenotype including steatosis, inflammation and fibrosis involving multiple cell-cell cross talks. The above model would mimic the in-vivo disease physiology and thus increases the accurate prediction of drug effect during NASH drug discovery. Our organoid model is suitable for long-term culture with more than two weeks of assay window for the dosing of potential anti-steatosis, anti-inflammatory and anti-fibrotic drugs
3D cultured organoids are not only emerging as the platform for drug screening and disease modeling, but also have a potential in regenerative medicine and therapy. We, at Pandorum, aim to develop 3D bio-printed vascularized mini-organ or organ patches with the potential of engrafting on to the host tissue upon transplantation. Currently we’re developing a prototype for the same.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.